NANOBIOTIX Announces First Patient Injected with NBTXR3 in Pancreatic Cancer and Safe to Proceed Notifications for Two Additional Trials From U.S. FDA - ECEF

NANOBIOTIX Announces First Patient Injected with NBTXR3 in Pancreatic Cancer and Safe to Proceed Notifications for Two Additional Trials From U.S. FDA

Two Additional Phase I Studies in Lung and Esophageal Cancer Pending

https://www.financialbuzz.com/nanobiotix-announces-first-patient-injected-with-nbtxr3-in-pancreatic-cancer-and-safe-to-proceed-notifications-for-two-additional-trials-from-u-s-fda/

Leave a comment

Leave a Reply Cancel reply

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© Copyright 2014. ECEF. All rights reserved.

New York Website Design by: